Security key
76155X118
Revolution Medicines, Inc. - *W EXP 12/17/202 (RVMDW)
CUSIP: 76155X118
Q1 2025 13F Holders as of 31 Mar 2025
- Type / Class
- Equity / *W EXP 12/17/202
- Total 13F shares
- 7,647,321
- Share change
- +40,052
- Total reported value
- $298,455
- Price per share
- $0.04
- Number of holders
- 22
- Value change
- -$13,607
- Number of buys
- 5
- Number of sells
- 4
Report period
Q1 2025
Institutions
22
Top holders
10
RVMDW full security history
Newer quarter: Q2 2025
Previous quarter: Q4 2024
Revolution Medicines, Inc. SEC filings
Revolution Medicines, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 76155X118
Recent filing periods:
Top shareholders of RVMDW - Revolution Medicines, Inc. - *W EXP 12/17/202 (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| VANGUARD GROUP INC |
13F
|
Company |
8.6%
|
17,096,455
|
$747,798,942 | — | 31 Dec 2024 | |
| BlackRock, Inc. |
13F
|
Company |
7.4%
|
14,719,548
|
$643,833,029 | — | 31 Dec 2024 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
5.4%
|
10,821,691
|
$473,340,765 | — | 31 Dec 2024 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
4.8%
|
9,483,999
|
$414,777,363 | — | 31 Dec 2024 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
4%
|
7,936,972
|
$347,163,155 | — | 31 Dec 2024 | |
| Nextech Invest Ltd. |
13F
|
Company |
3.8%
|
7,601,087
|
$332,471,545 | — | 31 Dec 2024 | |
| FMR LLC |
13F
|
Company |
3.4%
|
6,742,083
|
$294,898,713 | — | 31 Dec 2024 | |
| Paradigm Biocapital Advisors LP |
13F
|
Company |
3.3%
|
6,553,111
|
$286,633,075 | — | 31 Dec 2024 | |
| STATE STREET CORP |
13F
|
Company |
2.9%
|
5,791,752
|
$253,331,232 | — | 31 Dec 2024 | |
| Bellevue Group AG |
13F
|
Company |
2.2%
|
4,386,900
|
$191,883,006 | — | 31 Dec 2024 | |
| Boxer Capital Management, LLC |
13F
|
Company |
2.1%
|
4,279,464
|
$187,183,755 | — | 31 Dec 2024 | |
| BVF INC/IL |
13F
|
Company |
2.1%
|
4,181,179
|
$182,884,769 | — | 31 Dec 2024 | |
| Alphabet Inc. |
13F
|
Company |
2.1%
|
4,133,277
|
$180,790,062 | — | 31 Dec 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2.1%
|
4,086,199
|
$180,170,507 | — | 31 Dec 2024 | |
| Woodline Partners LP |
13F
|
Company |
1.9%
|
3,885,713
|
$169,961,087 | — | 31 Dec 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
1.9%
|
3,829,349
|
$167,495,738 | — | 31 Dec 2024 | |
| Casdin Capital, LLC |
13F
|
Company |
1.9%
|
3,699,283
|
$161,806,638 | — | 31 Dec 2024 | |
| DEERFIELD MANAGEMENT COMPANY, L.P. |
13F
|
Company |
1.6%
|
3,258,332
|
$142,519,442 | — | 31 Dec 2024 | |
| Holocene Advisors, LP |
13F
|
Company |
1.5%
|
2,996,710
|
$131,076,095 | — | 31 Dec 2024 | |
| a16z Capital Management, L.L.C. |
13F
|
Company |
1.4%
|
2,748,523
|
$120,220,396 | — | 31 Dec 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
1.3%
|
2,630,152
|
$115,042,849 | — | 31 Dec 2024 | |
| Lunate Holding RSC Ltd |
13F
|
Company |
1.1%
|
2,196,200
|
$96,061,788 | — | 31 Dec 2024 | |
| LORD, ABBETT & CO. LLC |
13F
|
Company |
0.99%
|
1,978,720
|
$86,549,000 | — | 31 Dec 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.97%
|
1,931,114
|
$84,466,926 | — | 31 Dec 2024 | |
| NORGES BANK |
13F
|
Company |
0.87%
|
1,742,039
|
$76,196,786 | — | 31 Dec 2024 | |
| Hood River Capital Management LLC |
13F
|
Company |
0.84%
|
1,678,434
|
$73,414,703 | — | 31 Dec 2024 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.82%
|
1,626,848
|
$71,158,342 | — | 31 Dec 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.77%
|
1,540,078
|
$67,363,012 | — | 31 Dec 2024 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.75%
|
1,504,801
|
$65,819,996 | — | 31 Dec 2024 | |
| Logos Global Management LP |
13F
|
Company |
0.73%
|
1,450,000
|
$63,423,000 | — | 31 Dec 2024 | |
| BALYASNY ASSET MANAGEMENT L.P. |
13F
|
Company |
0.65%
|
1,302,848
|
$56,986,572 | — | 31 Dec 2024 | |
| Rock Springs Capital Management LP |
13F
|
Company |
0.61%
|
1,213,257
|
$53,067,861 | — | 31 Dec 2024 | |
| Frazier Life Sciences Management, L.P. |
13F
|
Company |
0.5%
|
997,455
|
$43,628,682 | — | 31 Dec 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.43%
|
858,278
|
$37,541,123 | — | 31 Dec 2024 | |
| Polar Capital Holdings Plc |
13F
|
Company |
0.38%
|
750,665
|
$32,834,087 | — | 31 Dec 2024 | |
| Pictet Asset Management Holding SA |
13F
|
Company |
0.36%
|
712,596
|
$31,168,949 | — | 31 Dec 2024 | |
| Finepoint Capital LP |
13F
|
Company |
0.36%
|
710,260
|
$31,066,772 | — | 31 Dec 2024 | |
| S.c.a. Candriam |
13F
|
Individual |
0.33%
|
656,740
|
$28,725,808 | — | 31 Dec 2024 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
0.32%
|
641,646
|
$28,065,626 | — | 31 Dec 2024 | |
| DAFNA Capital Management LLC |
13F
|
Company |
0.32%
|
631,176
|
$27,607,638 | — | 31 Dec 2024 | |
| Siren, L.L.C. |
13F
|
Individual |
0.29%
|
571,548
|
$24,999,510 | — | 31 Dec 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.29%
|
569,015
|
$24,888,720 | — | 31 Dec 2024 | |
| Integral Health Asset Management, LLC |
13F
|
Company |
0.28%
|
550,000
|
$24,057,000 | — | 31 Dec 2024 | |
| MIC Capital Management UK LLP |
13F
|
Company |
0.26%
|
508,569
|
$22,244,808 | — | 31 Dec 2024 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.24%
|
473,728
|
$20,720,863 | — | 31 Dec 2024 | |
| Avidity Partners Management LP |
13F
|
Company |
0.22%
|
446,200
|
$19,516,788 | — | 31 Dec 2024 | |
| VICTORY CAPITAL MANAGEMENT INC |
13F
|
Company |
0.22%
|
430,462
|
$18,828,407 | — | 31 Dec 2024 | |
| BARCLAYS PLC |
13F
|
Company |
0.21%
|
408,614
|
$17,872,776 | — | 31 Dec 2024 | |
| First Turn Management, LLC |
13F
|
Company |
0.2%
|
403,915
|
$17,667,242 | — | 31 Dec 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.2%
|
401,043
|
$17,541,621 | — | 31 Dec 2024 |
Institutional Holders of Revolution Medicines, Inc. - *W EXP 12/17/202 (RVMDW) as of Q1 2025
As of 31 Mar 2025,
Revolution Medicines, Inc. - *W EXP 12/17/202 (RVMDW) was held by
22 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
7,647,321 shares.
The largest 10 holders included
LMR Partners LLP, D. E. Shaw & Co., Inc., PRICE T ROWE ASSOCIATES INC /MD/, ADAGE CAPITAL PARTNERS GP, L.L.C., SOROS CAPITAL MANAGEMENT LLC, ARISTEIA CAPITAL, L.L.C., PERCEPTIVE ADVISORS LLC, TORONTO DOMINION BANK, Bleichroeder LP, and Sculptor Capital LP.
This page lists
22
institutional shareholders reporting positions in this security
for the Q1 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2025 vs Q4 2024 Across Filers
Q4 2024 holders
20
Q1 2025 holders
22
Holder diff
2
| Investor | Q4 2024 Shares | Q1 2025 Shares | Share Diff | Share Chg % | Q4 2024 Value $ | Q1 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.